CHAIRMAN: DR. KHALID BIN THANI AL THANI
EDITOR-IN-CHIEF: PROF. KHALID MUBARAK AL-SHAFI

World / Asia

Moderna in talks with South Korea to supply about 40 mln doses of COVID-19 vaccine

Published: 30 Dec 2020 - 12:41 am | Last Updated: 08 Nov 2021 - 01:55 pm
FILE PHOTO: Vials with a sticker reading,

FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration//File Photo

Reuters

SEOUL - Moderna Inc said on Tuesday it was in discussions with the South Korean government to potentially provide 40 million or more doses of its COVID-19 vaccine.

Potential distribution of the two-dose vaccine in South Korea is expected to start in the second quarter of 2021, the company said in a statement. 

Earlier on Tuesday, the Yonhap news agency citing the presidential office reported that South Korea will sign a deal with the vaccine developer to offer COVID-19 vaccines for 20 million people.

This comes a day after officials vowed to speed up efforts to launch a public coronavirus vaccination programme as the country detected its first cases of the virus variant linked to the rapid rise in infections in Britain.